Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target

被引:1
|
作者
Dattani, Abhishek [1 ]
Singh, Anvesha
Mccann, Gerry P.
Gulsin, Gaurav S.
机构
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, England
关键词
diabetes; calcium handling; manganese-enhanced MRI; GLYCATION END-PRODUCTS; SARCOPLASMIC-RETICULUM CA2+-ATPASE; CONGESTIVE-HEART-FAILURE; DIASTOLIC DYSFUNCTION; VENTRICULAR MYOCYTES; CARDIAC STRUCTURE; GENE-EXPRESSION; MANGANESE IONS; YOUNG-ADULTS; CARDIOMYOPATHY;
D O I
10.3390/jcdd11010012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes (T2D) is a multisystem disease with rapidly increasing global prevalence. Heart failure has emerged as a major complication of T2D. Dysregulated myocardial calcium handling is evident in the failing heart and this may be a key driver of cardiomyopathy in T2D, but until recently this has only been demonstrated in animal models. In this review, we describe the physiological concepts behind calcium handling within the cardiomyocyte and the application of novel imaging techniques for the quantification of myocardial calcium uptake. We take an in-depth look at the evidence for the impairment of calcium handling in T2D using pre-clinical models as well as in vivo studies, following which we discuss potential novel therapeutic approaches targeting dysregulated myocardial calcium handling in T2D.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] The Role of the Kidney in Hyperglycemia A New Therapeutic Target in Type 2 Diabetes Mellitus
    Hinnen, Debbie
    JOURNAL OF CARDIOVASCULAR NURSING, 2013, 28 (02) : 157 - 165
  • [32] FoxO1 signaling as a therapeutic target for type 2 diabetes and obesity
    Benchoula, Khaled
    Arya, Aditya
    Parhar, Ishwar S.
    Hwa, Wong Eng
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 891
  • [33] Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications
    Yang, Xi-Ding
    Yang, Yong-Yu
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [34] Glutamine Metabolism in Macrophages: A Novel Target for Obesity/Type 2 Diabetes
    Ren, Wenkai
    Xia, Yaoyao
    Chen, Siyuan
    Wu, Guoyao
    Bazer, Fuller W.
    Zhou, Beiyan
    Tan, Bie
    Zhu, Guoqiang
    Deng, Jinping
    Yin, Yulong
    ADVANCES IN NUTRITION, 2019, 10 (02) : 321 - 330
  • [35] Cardiac Autoimmunity as a Novel Biomarker, Mediator, and Therapeutic Target of Heart Disease in Type 1 Diabetes
    Myra A. Lipes
    Alfonso Galderisi
    Current Diabetes Reports, 2015, 15
  • [36] Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes
    Hallakou-Bozec, Sophie
    Vial, Guillaume
    Kergoat, Micheline
    Fouqueray, Pascale
    Bolze, Sebastien
    Borel, Anne-Laure
    Fontaine, Eric
    Moller, David E.
    DIABETES OBESITY & METABOLISM, 2021, 23 (03) : 664 - 673
  • [37] ASPROSIN AND TYPE 2 DIABETES MELLITUS: A NOVEL POTENTIAL THERAPEUTIC IMPLICATION
    Bhadel, P.
    Shrestha, S.
    Sapkota, B.
    Li, J-Y.
    Tao, H.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (01) : 1 - 7
  • [38] Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes
    Song, Zhihui
    Yan, An
    Guo, Zehui
    Zhang, Yuhang
    Wen, Tao
    Li, Zhenzhen
    Yang, Zhihua
    Chen, Rui
    Wang, Yi
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [39] Retinoids have therapeutic action in type 2 diabetes
    Meerza, Dilnasheen
    Iqbal, Sarah
    Zaheer, Sufian
    Naseem, Imrana
    NUTRITION, 2016, 32 (7-8) : 898 - 903
  • [40] Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes
    Mirzadeh, Zaman
    Faber, Chelsea L.
    Schwartz, Michael W.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 55 - 84